Literature DB >> 14753456

Prions prevent brain damage after experimental brain injury: a preliminary report.

S Hoshino1, K Inoue, T Yokoyama, S Kobayashi, T Asakura, A Teramoto, S Itohara.   

Abstract

The physiological function of the normal cellular form of prion protein (PrPC) is not yet fully understood. In the current study we used prion protein gene knock-out mice (Prnp-/-) to assess the role of PrPC in traumatic brain injury. Prnp+/- and Prnp-/- mice were subjected to weight-drop contusional brain injury over the left parietal cortex. Prnp-/- mice manifested a significantly larger lesion volume and worse neuromotor scores than did their Prnp+/- littermates. IgG immunostaining revealed that in Prnp-/- mice the breakdown in the blood-brain barrier (BBB) was more extensive at 1 month after brain injury. Our results are in agreement with previous in vitro findings of the neuroprotective role of PrPC and further support the hypothesis that functional loss of PrPC plays a pathogenic role in prion diseases. We also suggest that PrPC modulates BBB function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753456     DOI: 10.1007/978-3-7091-0651-8_64

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  19 in total

1.  Neuroprotective effects of the cellular prion protein in autoimmune optic neuritis.

Authors:  Sarah K Williams; Richard Fairless; Jens Weise; Ulrich Kalinke; Walter Schulz-Schaeffer; Ricarda Diem
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 2.  Cellular prion protein neuroprotective function: implications in prion diseases.

Authors:  Xavier Roucou; Andréa C LeBlanc
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

3.  Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice.

Authors:  Daisuke Yoshikawa; Naohiro Yamaguchi; Daisuke Ishibashi; Hitoki Yamanaka; Nobuhiko Okimura; Yoshitaka Yamaguchi; Tsuyoshi Mori; Hironori Miyata; Kazuto Shigematsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

Review 4.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

5.  Examining the Neural and Astroglial Protective Effects of Cellular Prion Protein Expression and Cell Death Protease Inhibition in Mouse Cerebrocortical Mixed Cultures.

Authors:  Kevin K W Wang; Zhihui Yang; Allen Chiu; Fan Lin; Richard Rubenstein
Journal:  Mol Neurobiol       Date:  2015-09-04       Impact factor: 5.590

6.  Primary blast-induced traumatic brain injury in rats leads to increased prion protein in plasma: a potential biomarker for blast-induced traumatic brain injury.

Authors:  Nam Pham; Thomas W Sawyer; Yushan Wang; Ferdous Rastgar Jazii; Cory Vair; Changiz Taghibiglou
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

7.  Antagonistic roles of the N-terminal domain of prion protein to doppel.

Authors:  Suehiro Sakaguchi
Journal:  Prion       Date:  2008-07-14       Impact factor: 3.931

8.  Infection of prions and treatment of PrP106-126 alter the endogenous status of protein 14-3-3 and trigger the mitochondrial apoptosis possibly via activating Bax pathway.

Authors:  Qi Shi; Qin-Qin Song; Peng Sun; Jin Zhang; Juan Song; Li-Na Chen; Kang Xiao; Shao-Bin Wang; Ya-Zhou Zhang; Gong-Qi Li; Lin-Jun Sheng; Bao-Dong Wang; Ming-Zhi Lu; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-10-18       Impact factor: 5.590

9.  The prion protein knockout mouse: a phenotype under challenge.

Authors:  Andrew D Steele; Susan Lindquist; Adriano Aguzzi
Journal:  Prion       Date:  2007-04-25       Impact factor: 3.931

Review 10.  Prion neurotoxicity: insights from prion protein mutants.

Authors:  Isaac H Solomon; Jessie A Schepker; David A Harris
Journal:  Curr Issues Mol Biol       Date:  2009-09-18       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.